Cargando…

Malignant gliomas: old and new systemic treatment approaches

BACKGROUND: Malignant (high-grade) gliomas are rapidly progressive brain tumours with very high morbidity and mortality. Until recently, treatment options for patients with malignant gliomas were limited and mainly the same for all subtypes of malignant gliomas. The treatment included surgery and ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesti, Tanja, Ocvirk, Janja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852970/
https://www.ncbi.nlm.nih.gov/pubmed/27247544
http://dx.doi.org/10.1515/raon-2015-0003
_version_ 1782430018968748032
author Mesti, Tanja
Ocvirk, Janja
author_facet Mesti, Tanja
Ocvirk, Janja
author_sort Mesti, Tanja
collection PubMed
description BACKGROUND: Malignant (high-grade) gliomas are rapidly progressive brain tumours with very high morbidity and mortality. Until recently, treatment options for patients with malignant gliomas were limited and mainly the same for all subtypes of malignant gliomas. The treatment included surgery and radiotherapy. Chemotherapy used as an adjuvant treatment or at recurrence had a marginal role. CONCLUSIONS: Nowadays, the treatment of malignant gliomas requires a multidisciplinary approach. The treatment includes surgery, radiotherapy and chemotherapy. The chosen approach is more complex and individually adjusted. By that, the effect on the survival and quality of life is notable higher.
format Online
Article
Text
id pubmed-4852970
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-48529702016-06-01 Malignant gliomas: old and new systemic treatment approaches Mesti, Tanja Ocvirk, Janja Radiol Oncol Review BACKGROUND: Malignant (high-grade) gliomas are rapidly progressive brain tumours with very high morbidity and mortality. Until recently, treatment options for patients with malignant gliomas were limited and mainly the same for all subtypes of malignant gliomas. The treatment included surgery and radiotherapy. Chemotherapy used as an adjuvant treatment or at recurrence had a marginal role. CONCLUSIONS: Nowadays, the treatment of malignant gliomas requires a multidisciplinary approach. The treatment includes surgery, radiotherapy and chemotherapy. The chosen approach is more complex and individually adjusted. By that, the effect on the survival and quality of life is notable higher. De Gruyter 2016-04-23 /pmc/articles/PMC4852970/ /pubmed/27247544 http://dx.doi.org/10.1515/raon-2015-0003 Text en © 2016 Radiol Oncol
spellingShingle Review
Mesti, Tanja
Ocvirk, Janja
Malignant gliomas: old and new systemic treatment approaches
title Malignant gliomas: old and new systemic treatment approaches
title_full Malignant gliomas: old and new systemic treatment approaches
title_fullStr Malignant gliomas: old and new systemic treatment approaches
title_full_unstemmed Malignant gliomas: old and new systemic treatment approaches
title_short Malignant gliomas: old and new systemic treatment approaches
title_sort malignant gliomas: old and new systemic treatment approaches
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852970/
https://www.ncbi.nlm.nih.gov/pubmed/27247544
http://dx.doi.org/10.1515/raon-2015-0003
work_keys_str_mv AT mestitanja malignantgliomasoldandnewsystemictreatmentapproaches
AT ocvirkjanja malignantgliomasoldandnewsystemictreatmentapproaches